Stay updated on Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Sign up to get notified when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new release entry appears in the study's history for version v3.5.5, replacing the previous v3.5.4 in the history. This reflects an update to the page's release notes rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-06-07T02:32:06.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.4, has been added to the history, and the previous v3.5.3 entry has been removed.
    Difference
    0.1%
    Check dated 2026-05-16T09:20:02.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page’s footer indicates an updated ClinicalTrials.gov interface revision from v3.5.2 to v3.5.3. This reflects a platform/version change rather than a change to the study record details.
    Difference
    0.1%
    Check dated 2026-04-25T06:20:55.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T03:53:08.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The Record History now includes a new version entry (v3.5.0) and removes the earlier version (v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-20T04:00:00.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the history and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T21:33:04.000Z thumbnail image

Stay in the know with updates to Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.